A new study in the JAMA Network Open claims to find that testosterone therapy “significantly reduce[s] gender dysphoria, depression, and suicidality in transgender and gender-diverse individuals desiring testosterone therapy.” The study, titled “Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization: A Randomized Clinical Trial,” is being celebrated by advocates of sex trait modification (STM) because it is the first randomized controlled trial (RCT) in this area of research.
